Who have Haemangioblastoma with Ultravist 240 - from FDA reports
There is no Haemangioblastoma reported by people who take Ultravist 240 yet. This review analyzes which people have Haemangioblastoma with Ultravist 240. It is created by eHealthMe based on reports from FDA, and is updated regularly.
How to use this study: bring a copy to your health teams to ensure drug risks and benefits are fully discussed and understood.
Peer to Peer mobile support
Peer support for this study is available on our Ginger Health app. It's free, anonymous and secure. The app is ideal for people taking multiple medications or having multiple conditions.
No report is found.
Do you have Haemangioblastoma while taking Ultravist 240?
- Check whether a drug or a condition causes Haemangioblastoma
- Subscribe to monitor Haemangioblastoma in Ultravist 240
You are not alone:
- Connect with people like you who take Ultravist 240 and have Haemangioblastoma
- Use your healthcare experience to help people like you, and be rewarded
Ultravist 240 has active ingredients of iopromide. (latest outcomes from Ultravist 240 55 users)
Haemangioblastoma (tumours of the central nervous system) has been reported by people with multiple sclerosis, rheumatoid arthritis, hypopituitarism, ankylosing spondylitis, osteoporosis (latest reports from 54 Haemangioblastoma patients).
Drugs that are associated with HaemangioblastomaHaemangioblastoma
Could your condition cause HaemangioblastomaHaemangioblastoma
Ultravist 240 side effects
- Ultravist 240 side effects (54 reports)
Browse by gender and age
Browse all side effects of Ultravist 240a b c d e f g h i j k l m n o p q r s t u v w x y z
What would happen?
Recent general studies
- Will you have Atherosclerosis with Famotidine? - now
- Will you have Hardening Of The Arteries with Famotidine? - now
- Will you have Arteriosclerosis with Famotidine? - now
- Will you have Plaque Buildup - Arteries with Famotidine? - now
- Will you have Ear Surgery - Cosmetic with Guaifenesin? - 2 seconds ago
- Will you have Denervation Atrophy with Forteo? - 2 seconds ago
- Will you have Porokeratosis with Atra? - 3 seconds ago
- Will you have Abulia with Probiotics? - 4 seconds ago
- What to expect when you take Atropen and have Oa? - 4 seconds ago
- Hctz and Radix Ginseng Rubra drug interaction - 5 seconds ago
Recent personal studies
- A study for a 83 year old woman who takes Tylenol, Morphine Sulfate, Robitussin - 2 hours ago
- Drug comparison of Effexor, Ventolin, Ritalin for a 32 year old woman - 3 hours ago
- A study for a 20 year old woman who takes Concerta - 8 hours ago
- A study for a 50 year old woman who takes Lipitor - 8 hours ago
- A study for a 50 year old woman who takes Spiriva Respimat, Prednisone - 9 hours ago
- A study for a 71 year old woman who takes Cymbalta, Lyrica - 9 hours ago
- A study for a 1 year old girl who takes Roxicodone - 9 hours ago
- A study for a 26 year old man who takes Ambien, Tagamet - 9 hours ago
- A study for a 22 year old woman who takes Vitamin B6 - 10 hours ago
- A study for a 24 year old woman who takes Vyvanse, Naltrexone Hydrochloride, Trileptal, Rozerem, Kyleena, Latuda, Lamictal - 10 hours ago
NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.